CerRx Receives $1.1 Million NIH Grant for Cancer Study - MyHighPlains.com

CerRx, Inc. (CerRx) today [Thursday] announced that it has been awarded a non-diluting National Institute of Health (NIH) grant of $1.1M to support a Phase I study combining its two lead investigational compounds intravenous (IV) fenretinide and IV safingol. These drugs act together to specifically kill cancer cells by increasing certain toxic ‘ceramide’ waxes in cancer cells.

...

C. Patrick Reynolds, M.D., Ph.D., chief scientific officer of CerRx and director at the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine Cancer Center, said, “The combination of fenretinide plus safingol provides a very exciting and novel approach to selectively attacking cancer cells of many types in adults and children and we are delighted that this imporant clinical trial will be carried out here in Texas.”

Read the full story >>

Related Stories

Willed Body Memorial Service Honors Those Who Donated

On Memorial Day each May, a service is conducted at the Texas Tech University Health Sciences Center Institute of Anatomical Sciences to pay respect to the Willed Body Program donors and their families.

Molecular Pathology Preceptorship: Unmatched Value and Experience

Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.

Moseley Named Permian Basin Regional Dean of the Texas Tech University Health Sciences Center School of Nursing

Kelly Moseley, DHSc, R.N., has been named the TTUHSC School of Nursing regional dean in the Permian Basin.

Recent Stories

Research

TTUHSC Teams Selected for 2025 Innosphere Life Sciences Accelerator Cohort

A pair of teams representing TTUHSC earned a spot among the 33 startup groups selected for the 2025 cohort of the Innosphere Life Sciences Accelerator.

Research

Exploring New Frontiers in Patient Care

Jenna Kesey, Ph.D., associate managing director for the Clinical Research Institute (CRI) at TTUHSC, said it's important that the university provides opportunities for its patients to have access to innovative therapies through the clinical trial process.

Willed Body Memorial Service Honors Those Who Donated

On Memorial Day each May, a service is conducted at the Texas Tech University Health Sciences Center Institute of Anatomical Sciences to pay respect to the Willed Body Program donors and their families.